Breachway Investments’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$777K Buy
30,850
+7,700
+33% +$194K 1.17% 26
2026
Q1
$583K Buy
23,150
+3,520
+18% +$89.8K 0.56% 38
2025
Q4
$501K Buy
+19,630
New +$502K 0.53% 49

Other funds holding IBDX

Breachway Investments's IBDX Position: Q2 2026 in Review

Breachway Investments increased its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 33% in Q2 2026, buying an estimated $194K and bringing the position to 30,850 shares worth $777K. The position accounts for 1.17% of the portfolio, ranked #26.

Breachway Investments first reported a position in IBDX in Q4 2025 and has held it in 3 quarters since. 150 funds tracked by Wall St. Rank hold IBDX as of Q2 2026.

  • Breachway Investments held 30,850 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $777K as of Q2 2026.
  • Breachway Investments bought 7,700 iShares iBonds Dec 2032 Term Corporate ETF shares in Q2 2026, an estimated $194K.
  • iShares iBonds Dec 2032 Term Corporate ETF made up 1.17% of Breachway Investments's portfolio in Q2 2026, its #26 holding.
  • Breachway Investments first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q4 2025 and has held it in 3 quarters since.
  • 150 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q2 2026.

Based on Breachway Investments's 13F filing for Q2 2026, filed 13 Jul 2026.